Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Wantong Medical plans to renew its engagement with Lixin Certified Public Accountants, with an estimated audit fee of 800k yuan in 2026.
Beijing Wandong Medical Technology Co., Ltd. (Stock Code: 600055, Stock Abbreviation: Wandong Medical) announced on March 26 that it intends to re-engage Lixin Certified Public Accountants LLP (Special General Partnership) (hereinafter referred to as “Lixin”) as the company’s audit firm for the year 2026. The announcement shows that the total audit fee for 2026 is expected to be 800k yuan, an increase from 600k yuan in 2025.
According to the announcement, Lixin is a member firm of the international accounting network BDO, has long been engaged in securities services, holds H-share audit qualifications, and is registered with the Public Company Accounting Oversight Board (PCAOB) in the United States. As of the end of 2025, Lixin has 300 partners and 2,523 licensed accountants. Its business income in 2025 (unaudited) was 5 billion yuan, including 800k yuan from audit services and 1.55 billion yuan from securities business. In 2025, Lixin provided annual report audit services for 770 listed companies, with audit fees totaling 916 million yuan, serving 73 listed clients in the same industry.
In terms of investor protection capabilities, by the end of 2025, Lixin had set aside 171 million yuan for professional risk funds, and its purchased professional insurance had a total compensation limit of 1.05 billion yuan, capable of covering civil liabilities arising from audit failures. The announcement also disclosed Lixin’s civil liability in civil lawsuits related to professional conduct over the past three years, with related compensation covered within the scope of professional insurance and properly handled. Regarding integrity records, over the past three years, Lixin has been subject to 7 administrative penalties, 42 supervision and management measures, 6 self-regulatory measures, and 3 disciplinary sanctions, involving 151 practitioners.
Project information indicates that the project partner for this audit is Zhou Zhengwen, the signing CPA is Fu Yaping, and the quality control reviewer is Ge Weijun. The three have not violated the independence requirements of the “Code of Professional Ethics for Chinese Certified Public Accountants” in the past three years and have no adverse records.
Regarding audit fees, the total audit fee for 2026 is 800k yuan, including 650k yuan for financial audit and 150k yuan for internal control audit. Compared to 2025, the total audit fee increased by 200k yuan, with financial audit fees rising by 150k yuan and internal control audit fees increasing by 50k yuan. The company stated that the 2026 audit fee was negotiated with the accounting firm based on factors such as business scale, industry, complexity of accounting treatments, and audit workload.
Regarding the re-engagement procedure, the company’s board of directors and audit committee have thoroughly reviewed Lixin’s qualifications, professional competence, investor protection ability, integrity, and independence, and believe it can meet the company’s audit requirements, agreeing to submit it for board approval. The 14th meeting of the 10th Board of Directors held on March 24, 2026, approved the “Proposal on Re-engaging the Accounting Firm,” which still needs to be submitted for shareholder approval and will take effect from the date of shareholder approval.
Click to view the original announcement >>
Disclaimer: The market carries risks; investment should be cautious. This article is automatically published by an AI model based on third-party databases and does not represent Sina Finance’s views. All information in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for accuracy. If you have any questions, contact biz@staff.sina.com.cn.